CD276 and neoplasm: To determine whether soluble B7-H3 monomers block B7H3.CAR EBVST targeting of B7-H3–positive tumor cells, we coincubated B7H3.CAR EBVSTs with tumor cells in the presence of soluble B7-H3 over 12 hours.